Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (5215)	12/3/1999 11:02:00 AM
From: DanZ	Respond to of 10293

Kevin, You are twisting my words again. I was merely responding to somebody who asked for possible reasons that Robert might not want to post his findings on this thread. The only fact about sales comes from the company as I have stated numerous times. The fact is that orders for Zicam were about $8 million with about six weeks left in the quarter. People can draw their own conclusions about sell through to consumers. It's obvious to me that if retailers ordered five times as much as their initial purchases, then there is sell through to consumers, or retailers must think there will be more sell through to consumers. Most retailers have sophisticated just in time inventory systems and they wouldn't order that much Zicam if they didn't think the demand supported it. Many retailers have also been advertising Zicam on their own nickle either with in-store ads or circulars. Bill: Thanks for your generous claim that Zicam is a cure for the common cold, but nobody affiliated with Gum Tech or Gel Tech uses that terminology to describe the product. It is a remedy for the common cold that reduces the duration and severity of symptoms better than anything else on the market. In fact, Dr. M. Seidman, a widely respected ENT from Detroit was recently quoted in a Gum Tech press release: This initial research on Zicam is quite significant. The term 'cure' is not scientifically applicable since the common cold is a self-limiting condition, but the degree of efficacy of the medication demonstrated by this first study is very impressive,' said Dr. Michael Seidman, MD, FACS, a medical consultant to the company in the Department of Otolaryngology at Henry Ford Medical Center, Detroit, Michigan. This is just another example of how you hype your short position by using terms that have a negative connotation. You are a manipulative scam artist and one day you will be shut down, if not by your own lousy record, by a proactive effort on the part of a company or companies that you have libeled, or the SEC for securities fraud.